VivoSense, Inc. stands out as a global leader in data analysis consulting and software, particularly in the niche of wearable sensor physiological monitoring solutions for clinical trials, healthcare research, and consumer wellness. The company's unique competitive edge lies in its development of regulatory compliant digital biomarkers from wearable sensor data, a first in the analytics industry, which are now primary and secondary clinical endpoints in regulated international pharmaceutical trials. Their commitment to research and development is evident in their collaboration with the University of Massachusetts Amherst, resulting in a published review paper in the Journal of Alzheimer’s Disease.